- CA$0.84m
- CA$0.92m
- CA$0.01m
- 16
- 60
- 58
- 41
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.018 | 0.032 | 0.327 | 0.078 | 0.005 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.58 | 6.75 | 2.02 | 2.5 | 3.05 |
Operating Profit | -6.56 | -6.72 | -1.69 | -2.42 | -3.04 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.38 | -6.88 | -1.8 | -2.58 | -3.09 |
Net Income After Taxes | -6.38 | -6.88 | -1.8 | -2.58 | -3.09 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.38 | -6.88 | -1.8 | -2.58 | -3.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.38 | -6.88 | -1.8 | -2.58 | -3.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.764 | -0.66 | -0.188 | -0.137 | -0.089 |